What was initial cholesterol level before lipitor dose change?

No specific initial cholesterol level is documented in publicly available clinical trial data or prescribing information for Lipitor (atorvastatin) dose changes, as trials tested various starting levels rather than a single baseline.[1]

How Lipitor trials set baseline cholesterol

Major trials like ASCOT-LLA enrolled patients with LDL cholesterol between 130-190 mg/dL (3.4-4.9 mmol/L) or higher if other cardiovascular risks existed, before initiating or adjusting doses from 10 mg to 80 mg daily.[1][2] Levels weren't uniform; physicians titrated based on response, targeting <100 mg/dL for high-risk patients.

What triggers a Lipitor dose change

Guidelines recommend rechecking lipids 4-12 weeks after starting Lipitor, increasing dose if LDL remains >100 mg/dL (or >70 mg/dL in very high-risk cases). No fixed 'initial' threshold exists—it's individualized per ACC/AHA risk calculators.[3]

Typical cholesterol levels prompting escalation

• High-risk patients: Often start at 10-20 mg if baseline LDL >130 mg/dL.
  
• Dose-up examples: From 10 mg to 20-40 mg if LDL drops <30-50% from baseline >150 mg/dL.[2]
  Real-world data shows average baseline LDL around 150-160 mg/dL before adjustments.[4]
  
  

Lipitor patent and generic timeline

Lipitor's key composition patent expired November 2011, allowing generics at all doses. No cholesterol-specific patent ties to dose changes.[5]

[1]: Lipitor Prescribing Information (Pfizer)
[2]: NEJM: ASCOT-LLA Trial (2003)
[3]: ACC/AHA Cholesterol Guidelines (2018)
[4]: JAMA: Atorvastatin Real-World Outcomes
[5]: DrugPatentWatch: Lipitor Patents